Data as of Apr 17
| +0.25 / +2.29%|
The 9 analysts offering 12-month price forecasts for Astellas Pharma Inc have a median target of 17.62, with a high estimate of 22.78 and a low estimate of 14.69. The median estimate represents a +57.78% increase from the last price of 11.17.
The current consensus among 13 polled investment analysts is to Buy stock in Astellas Pharma Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.